Company Overview
Since its formation in 1992, Trinity Biotech has actively pursued the aim of becoming a leading player in the international diagnostics industry. A combination of strong organic growth and a progressive acquisition-led strategy has seen the company assemble an impressive portfolio of over 500 products to date. Specialising in the development, manufacture and marketing of diagnostic test kits, Trinity Biotech’s continued success is based on the fact that as a company it consistently achieves standards of excellence in the quality of all it does. Trinity Biotech, which has its headquarters in Bray, sells its products in more than 80 countries
Number of employees over 700 people History of the company
Trinity Biotech was founded in 1992 and listed on the NASDAQ market shortly after its formation. Through a combination of sustained, organic growth and an acquisition-led strategy, the company has assembled an impressive product portfolio and achieved the highest standards of excellence in developing, manufacturing and marketing diagnostic products. Today Trinity Biotech is listed on the NASDAQ Global Select Market, and has approximately 18 million American Depository Shares. |